LENSAR, Inc. (LNSR) Financials
LNSR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 69.6 million | 22.4 million |
2023-09-30 | 70.9 million | 34.5 million |
2023-06-30 | 71.2 million | 38.5 million |
2023-03-31 | 52.0 million | 12.5 million |
LNSR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -525000 | 816000 |
2023-09-30 | -341000 | 1.2 million |
2023-06-30 | -2.3 million | 1.8 million |
2023-03-31 | -6.7 million | 1.7 million |
LNSR Net Income
No data available :(
LNSR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 24.1 million | - | 2.3 million |
2023-09-30 | 24.9 million | - | 2.4 million |
2023-06-30 | 25.5 million | - | 2.6 million |
2023-03-31 | 8.0 million | - | 2.7 million |
LNSR Shares Outstanding
LNSR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 45000 | 1.5 million | 6.4 million | - |
2023-09-30 | 2000 | 1.5 million | 5.1 million | - |
2023-06-30 | 181000 | 1.5 million | 7.9 million | - |
2023-03-31 | 8000 | 1.7 million | 6.8 million | - |
LNSR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 12.1 million | 7.2 million |
2023-09-30 | 9.8 million | 4.9 million |
2023-06-30 | 12.0 million | 5.3 million |
2023-03-31 | 8.3 million | 3.9 million |
LNSR
Price: $3.24
52 week price:
Earnings Per Share: -1.31 USD
P/E Ratio: -3.95
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 3193
Market Capitalization: 37.4 million